top
Search terms
Results 1 - 10 of 153 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 16
Ehjcvp

Vice versa, patients presenting with acute coronary syndromes (ACS) develop AF in 621% of cases, hence, through the presence of vascular disease, these patients automatically require anticoagulation ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Miklos Rohla, Thomas W. Weiss, Johann Wojta, Alexander Niessner, Kurt Huber

Date : 01/07/2015 Item size : 293945 bytes
Ehjcvp

Effect of rapid desensitization on platelet inhibition and basophil activation in patients with aspirin hypersensitivity and coronary disease Cases were patients with coronary artery disease (CAD) ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Stéphane Manzo-Silberman, Pascale Nicaise-Roland, Catherine Neukirch, Florence Tubach, Marie-Geneviève Huisse, Sylvie ...

Date : 05/08/2016 Item size : 209243 bytes
Ehjcvp

Introduction Dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a P2Y12 inhibitor, is recommended by guidelines for up to 12 months in patients with acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Articles, Gianluigi Savarese, Stefano Savonitto, Lars H. Lund, Stefania Paolillo, Caterina Marciano, Santo Dellegrottaglie, Antonio ...

Date : 01/10/2016 Item size : 333679 bytes
Eurointervention

Barwari A., Allawi N., Ahmed A. AIMS The current study is the first study from Iraq to address the different allelic variants of the gene CYP2C19, and to correlate them to the major cardiovascular ...

Date : 06/05/2016 Item size : 31434 bytes
Eurointervention

EuroIntervention Impact of chronic kidney disease on two-year clinical outcomes in patients treated with a six-month or 24-month DAPT duration: insights from the PRODIGY trial Santucci A., Gargiulo ...

Date : 06/05/2016 Item size : 31472 bytes
Eurointervention

Women (n=459; 23.3%) were older, more likely to have hypertension, lower creatinine clearance, and acute coronary syndrome (ACS), but had a lower severity of coronary artery disease (CAD). After ...

Date : 06/05/2016 Item size : 31487 bytes
Eurointervention

METHODS AND RESULTS The Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus-Eluting Stent in the Real World Clinical Practice (OPTIMIZE) was an open-label, ...

Date : 06/05/2016 Item size : 31518 bytes
Eurointervention

EuroIntervention Two-year outcomes of an everolimus-eluting BRS in real-world coronary artery disease Robaei D., Spies M., Back L., Kushwaha V., Ooi S., Giles R., Pitney M., Jepson N. AIMS To ...

Date : 06/05/2016 Item size : 32778 bytes
Eurointervention

EuroIntervention Impact of stent type and prolonged DAPT on long-term clinical outcomes in haemodialysis patients with coronary artery disease Asami M., Aoki J., Sato T., Tanimoto S., Watanabe M., ...

Date : 06/05/2016 Item size : 31385 bytes
Eurointervention

EuroIntervention A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients Department of Interventional Cardiology, Erasmus ...

Date : 18/01/2013 Item size : 36803 bytes